James E Galvin
Works at
University of Miami School of Medicine
Professor17 Sept 2026reporter.nih.gov
Institute for Molecular Medicine
25 Aug 2026reporter.nih.gov
Grants and prizes
Proof of Concept (Phase 0) Study of Clinical Trial Outcomes and Biomarkers in Early Stage Dementia with Lewy BodiesR01AG10041917 Sept 2026reporter.nih.gov
R01Project LEARNS: Learning Alzheimer’s Results and Next StepsR01AG0939302026–203126 Aug 2026reporter.nih.gov
R01FDA approved IND 29644: Multicenter Phase 1 Trial to Evaluate Safety and Immunogenicity of Preventive Tau Vaccine, AV-1980R/A, in cognitively unimpaired preclinical AD participants.R01AG0929492025–203025 Aug 2026reporter.nih.gov
U01IND enabling CMC/safety/toxicology studies, submission of IND and pilot Phase 1 clinical trial with PV-1950R vaccine for Lewy Body Dementia (LBD)U01AG0845282024–202910 Aug 2026reporter.nih.gov